Article Text

Download PDFPDF
Observational study
Are cherries now ripe for use as a complementary therapeutic in gout? Appraisal of the state of evidence
  1. Robert Terkeltaub
  1. Department of Medicine, VAMC/UCSD, San Diego, California, USA
  1. Correspondence to Dr Robert Terkeltaub
    VAMC/UCSD Medicine, 3350 La Jolla Village Drive, San Diego, CA 92161, USA; rterkeltaub{at}ucsd.edu

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Commentary on: OpenUrlCrossRefPubMedWeb of Science

Context

The prevalence of gout has risen in the USA and many other countries, owing to a ‘perfect storm’ of factors, including increased prevalence of comorbid conditions, and diet and alcohol consumption megatrends. Resultant increase in clinical complexity of gouty arthritis and hyperuricaemia management is compounded by relatively poor patient adherence compared to many other medical conditions. This is partly because of gaps in patient and physician education. Notwithstanding, there is substantial interest by patients and clinicians in inexpensive and health-promoting non-pharmacological modalities to potentially improve gout management. Cherries and cherry products, buttressed by an initial uncontrolled study,1 are a popular folk remedy for gout, as evidenced by more than 1 600 000 ‘hits’ (as of January 2013) in an internet search for …

View Full Text

Footnotes

  • Competing interests RT has undertaken work as a consultant for Takeda, Savient, BioCryst, ARDEA, Metabolex, URL, Regeneron, Novartis and Pfizer.